Financial intelligence for Asia's healthcare markets
Remember me:

News articles    

Eluminex Biosciences, an ophthalmic biotechnology company has completed a $50 million Series A financing co-led by Lilly Asia Ventures, GL Ventures (venture capital arm of Hillhouse Capital), and Quan Capital.
TVM Capital Healthcare, a global private equity and growth capital firm focused on emerging markets, has announced two team additions today.
In partnership with VeChain and DNV GL, Renji Hospital, a hospital in China affiliated with the Shanghai Jiaotong University School of Medicine, has launched the world's first blockchain-enabled intelligent tumour treatment centre.
Hong Kong-based BuyHive, a new global sourcing start-up that connects buyers with trusted verified overseas suppliers, has launched a PPE programme to help US companies optimise their post-Covid supply chains.
Singapore health technology start-up X-Zell has closed an oversubscribed Seed+ round led by German industrial service group, Deutsche Industrieanlagen.
Shanghai-based digital healthcare platform 111 Inc and Hainan Huluwa Pharmaceutical Group Co. have signed a strategic partnership agreement.
Malaysia's healthcare tourism industry is showing some encouraging signs of recovery after the government opened its borders in phases to international patients, beginning 1 July after a Recovery Movement Control Order began.
Elvie, a women’s health technology company is expanding into China and the US after securing following funding from HSBC in the UK.
South Korean medical devices manufacturer Medifiber has signed a deal with UK medtech company Copper Clothing fior the supply of copper-infused face masks to the UK market.
Petaling Jaya-based corporate healthcare benefits and wellness management platform HealthMetrics has raised $5 as part of a Series A funding in a round led by ACA Investments.

Subscribe to our news RSS feed Get the RSS for HealthInvestor Asia




The IPO market in Hong Kong is hotting up again and it looks as though 2019 is going to be as busy with biotech company floats as last year was.



HealthInvestor Asia twitter feed


HealthInvestor UK